Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2

Growth hormone receptor (GHR) plays a vital role in breast cancer chemoresistance and metastasis but the mechanism is not fully understood. We determined if GHR could be a potential therapeutic target for estrogen receptor negative (ER−ve) breast cancer, which are highly chemoresistant and metastati...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Exp Mol Med
Päätekijät: Arumugam, Arunkumar, Subramani, Ramadevi, Nandy, Sushmita Bose, Terreros, Daniel, Dwivedi, Alok Kumar, Saltzstein, Edward, Lakshmanaswamy, Rajkumar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6323053/
https://ncbi.nlm.nih.gov/pubmed/30617282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-018-0197-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia